BioAdaptives, Inc. (BDPT)

Market Cap	363.26K
Revenue (ttm)	3.22K
Net Income (ttm)	-764.49K
Shares Out	12.01M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	92,600
Average Volume	222,291
Open	0.0330
Previous Close	0.0273
Day's Range	0.0303 - 0.0330
52-Week Range	0.0100 - 0.3600
Beta	0.93
RSI	48.08
Earnings Date	Nov 14, 2025

About BioAdaptives

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BDPT

Financial Performance

In 2024, BioAdaptives's revenue was $12,669, a decrease of -55.65% compared to the previous year's $28,565. Losses were -$899,161, 26.2% more than in 2023.